FDA.reportPublic FDA data

Oracea 40 MG Delayed Release Oral Capsule

RxCUI
901401
RxNorm name
Oracea 40 MG Delayed Release Oral Capsule
Display name
Oracea 40 MG Delayed Release Oral Capsule
Full name
Oracea 40 MG Delayed Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ORACEADOXYCYCLINEGalderma Laboratories, L.P.aa15c93a-ff4c-447a-8a21-96da506d89972025-04-16Warnings, Adverse reactionsExact identifier
rxcui: 901401

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aa15c93a-ff4c-447a-8a21-96da506d8997Oracea 40 MG Delayed Release Oral Capsule [PSN] · doxycycline anhydrous 40 MG Delayed Release Oral Capsule [Oracea] [SBD] · Oracea 40 MG Delayed Release Oral Capsule [SY]323These highlights do not include all the information needed to use ORACEA ® safely and effectively. See full prescribing information for ORACEA. ORACEA (doxycycline) capsules for oral use. Initial U.S. Approval: 196720250416
4e954825-3f60-4dbb-a1be-b146fe1acae4Oracea 40 MG Delayed Release Oral Capsule [PSN] · doxycycline anhydrous 40 MG Delayed Release Oral Capsule [Oracea] [SBD] · Oracea 40 MG Delayed Release Oral Capsule [SY]3120091230